Status:
COMPLETED
Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
RATIONALE: Palliative care may help patients with advanced cancer live more comfortably. PURPOSE: This randomized clinical trial is studying an early intervention palliative care program to see how w...
Detailed Description
OBJECTIVES: * Determine the efficacy of an early intervention palliative care program comprising a phone-based nurse educator and shared medical appointments in improving end-of-life care of patients...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Diagnosis of 1 of the following advanced cancers:
- Stage IIIB or IV non-small cell lung cancer
- Extensive stage small cell lung cancer
- Stage IV breast cancer
- Poor prognostic indicators (conferring likelihood of ≤ 2 years survival), including, but not limited to, any of the following:
- Visceral crisis
- Lung or liver metastasis
- Estrogen receptor-negative disease
- HER2/neu-positive disease
- Progressive or recurrent disease during or within 2 years of first treatment
- Unresectable stage III or stage IV gastrointestinal cancers
- Stage IV genitourinary cancers
- Prostate cancer must be hormone refractory
- Hormone receptor status:
- Not specified
- PATIENT CHARACTERISTICS:
- Sex
- Not specified
- Menopausal status
- Not specified
- Performance status
- Not specified
- Life expectancy
- Not specified
- Hematopoietic
- Not specified
- Hepatic
- Not specified
- Renal
- Not specified
- Other
- No dementia or significant confusion (i.e., Mini Mental Exam score \< 25)
- No Axis I psychiatric disorders (DSM-IV), including any of the following:
- Schizophrenia
- Bipolar disorder
- Active substance use disorder
- PRIOR CONCURRENT THERAPY:
- Endocrine therapy
- See Disease Characteristics
Exclusion
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
329 Patients enrolled
Trial Details
Trial ID
NCT00253383
Start Date
January 1 2003
End Date
September 1 2013
Last Update
December 19 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03756-0002
2
Veterans Affairs Medical Center - White River Junction
White River Junction, Vermont, United States, 05009